
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.15 | 0.15 | 0.00 |
Stocks | 97.23 | 97.23 | 0.00 |
Other | 2.62 | 2.80 | 0.18 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.94 | 19.58 |
Price to Book | 4.99 | 4.48 |
Price to Sales | 3.73 | 2.54 |
Price to Cash Flow | 14.54 | 17.39 |
Dividend Yield | 1.03 | 1.09 |
5 Years Earnings Growth | 15.90 | 12.01 |
Number of long holdings: 185
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 14.25 | 201.64 | -1.73% | |
Amgen | US0311621009 | 7.85 | 309.85 | +1.36% | |
Krystal Biotech | US5011471027 | 6.97 | 178.13 | -1.59% | |
Vertex | US92532F1003 | 5.08 | 484.01 | +0.11% | |
Alnylam | US02043Q1076 | 4.38 | 262.16 | -1.75% | |
Gilead | US3755581036 | 3.74 | 112.39 | +0.45% | |
argenx ADR | US04016X1019 | 2.62 | 590.06 | +1.10% | |
UCB | BE0003739530 | 2.42 | 160.85 | -1.14% | |
Regeneron Pharma | US75886F1075 | 2.19 | 610.64 | -2.39% | |
Ascendis Pharma AS | US04351P1012 | 2.00 | 150.09 | -1.35% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 632.47B | 1.44 | 12.54 | 12.97 | ||
Fidelity Contrafund | 144.79B | 3.52 | 17.24 | 15.17 | ||
Fidelity Total Market Index Instl b | 106.34B | 1.12 | 11.54 | 12.30 | ||
Fidelity Blue Chip Growth | 61.8B | -2.84 | 15.11 | 17.11 | ||
Fidelity Growth Company | 57.87B | -3.07 | 14.73 | 17.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review